Возраст домена | n/a |
Дата окончания | n/a |
PR | 4 |
ИКС | 10 |
Страниц в Google | 138 |
Страниц в Яндексе | 108 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 581462 |
Alexa Country | 162421 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
RxAbbVie
n/a
n/a
UTF-8
34.37 КБ
1 003
8 518 симв.
7 409 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
humira.com | 40 | 4 |
0 | 203596 | 45390 | |
androgel.com | 40 | 4 |
0 | 1566544 | 443659 | |
androgelpro.com | 37 | 4 |
0 | 3225570 | 621297 | |
vicodin.com | 33 | 4 |
0 | 2282965 | 329460 | |
humirapro.com | 20 | 4 |
0 | 1300506 | 303888 | |
lupron.com | 14 | 4 |
0 | 4909863 | Нет данных | |
humira.co.nz | 11 | 3 |
0 | 10309379 | Нет данных | |
lupronped.com | 10 | 4 |
0 | 5219718 | Нет данных | |
lyza.com | 10 | 5 |
0 | 3654619 | 1654251 | |
androgeltestosterone.com | 7 | 2 |
0 | Нет данных | Нет данных | |
rxlist.com | 5 | 7 |
0 | 7347 | 1874 | |
healthcentral.com | 2 | 6 |
0 | 51279 | 10247 | |
healthboards.com | 1 | 5 |
0 | 169363 | 33000 | |
forbes.com | 1 | 8 |
0 | 289 | 109 | |
everydayhealth.com | 1 | 7 |
0 | 3797 | 1943 | |
emedtv.com | 1 | 5 |
10 | 231637 | 85990 | |
drugs.com | 1 | 7 |
0 | 3848 | 1398 | |
diabetesincontrol.com | 1 | 4 |
10 | 311194 | 103482 | |
cafepharma.com | 1 | 5 |
0 | 173271 | 41486 | |
Еще 31 сайт после авторизации |
Данные предоставлены сервисом semrush
Данные linkpad ( 16 Апреля 2016 ) | |
Количество ссылок на сайт | 511 |
Количество доменов, которые ссылаются на сайт | 91 |
Количество найденных анкоров | 79 |
Исходящие (внешние) ссылки домена | 3 |
Количество доменов, на которые ссылается сайт | 3 |
Количество исходящих анкоров | 3 |
Внешние ссылки главной страницы ( 6 ) | |
fda.gov/medwatch/ | www.fda.gov/medwatch |
pparx.org/ | www.pparx.org |
abbviemedinfo.com/ | www.abbviemedinfo.com |
abbvie.com/contactus.html | Contact Us |
abbvie.com/privacy.html | Privacy policy |
abbvie.com/termsofuse.html | Terms of use |
Внутренние ссылки главной страницы ( 102 ) | |
<img> | |
/pdf/androgel_PI.pdf | AndroGel® (testosterone gel) 1% Full Prescribing Information |
/pdf/androgel_medguide.pdf | AndroGel® (testosterone gel) 1% Medication Guide |
/pdf/androgel1_62_PI.pdf | AndroGel® (testosterone gel) 1.62% Full Prescribing Information |
/pdf/androgel1_62_medguide.pdf | AndroGel® (testosterone gel) 1.62% Medication Guide |
/pdf/creon_PI.pdf | CREON® (pancrelipase) Delayed-Release Capsules Full Prescribing Information |
/pdf/creon_pi_CHI.pdf | CREON® (pancrelipase) Delayed-Release Capsules Full Prescribing Information - Chinese |
/pdf/creon_pi_KOR.pdf | CREON® (pancrelipase) Delayed-Release Capsules Full Prescribing Information - Korean |
/pdf/creon_pi_RUS.pdf | CREON® (pancrelipase) Delayed-Release Capsules Full Prescribing Information - Russian |
/pdf/creon_pi_SPA.pdf | CREON® (pancrelipase) Delayed-Release Capsules Full Prescribing Information - Spanish |
/pdf/creon_medguide.pdf | CREON® (pancrelipase) Delayed-Release Capsules Medication Guide |
/pdf/depacon.pdf | Depacon® (valproate sodium injection) |
/pdf/depakene.pdf | DEPAKENE® (valproic acid capsules and oral solution, USP) |
/pdf/depakene_medguide.pdf | DEPAKENE® (valproic acid capsules and oral solution, USP) Medication Guide |
/pdf/depakote.pdf | Depakote® (divalproex sodium) Delayed-Release Tablets |
/pdf/depakote_medguide.pdf | Depakote® (divalproex sodium) Delayed-Release Tablets Medication Guide |
/pdf/dep3.pdf | Depakote® ER (divalproex sodium) Extended-Release Tablets |
/pdf/dep3_medguide.pdf | Depakote® ER (divalproex sodium) Extended-Release Tablets Medication Guide |
/pdf/dep2.pdf | Depakote® Sprinkle Capsules (divalproex sodium delayed-release capsules) |
/pdf/dep2_medguide.pdf | Depakote® Sprinkle Capsules (divalproex sodium delayed-release capsules) Medication Guide |
/pdf/duopa_pi.pdf | DUOPA (carbidopa and levodopa) enteral suspension Full Prescribing Information with Medication Guide and Patient Instructions Fo... |
/pdf/duopa_SPA.pdf | DUOPA (carbidopa and levodopa) enteral suspension Full Prescribing Information with Medication Guide and Patient Instructions Fo... |
/pdf/duopa_pump_manual.pdf | DUOPA (carbidopa and levodopa) enteral suspension CADD-Legacy® 1400 Pump Operator’s Manual |
/pdf/duopa_ifu_cpack.pdf.pdf | DUOPA: AbbVie Chest Pack Instructions For Use |
/pdf/duopa_ifu_cbpack.pdf.pdf | DUOPA: AbbVie Cross Body Pack Instructions For Use |
/pdf/duopa_ifu_hpack.pdf.pdf | DUOPA: AbbVie Hip Pack Instructions For Use |
/pdf/abbvie_instr_jtube_mrisupp.pdf | DUOPA: AbbVie J Tube Instructions For Use, Including MRI Safety Information Supplement |
/pdf/duopa_ifu_lvest.pdf.pdf | DUOPA: AbbVie Lightweight Vest Instructions For Use |
/pdf/abbvie_mrisupp.pdf | DUOPA: AbbVie MRI Safety Information Supplement |
/pdf/abbvie_instr_njtube.pdf | DUOPA: AbbVie NJ Tube Instructions For Use |
/pdf/abbvie_instr_pegtube.pdf | DUOPA: AbbVie PEG Tube Kit Instructions For Use |
/pdf/duopa_ifu_svest.pdf.pdf | DUOPA: AbbVie Snug Vest Instructions For Use |
/pdf/gengraf-cap.pdf | GENGRAF® Capsules (cyclosporine capsules, USP) |
/pdf/gengraf-oral.pdf | Gengraf® Oral Solution (cyclosporine oral solution, USP) |
/pdf/humira.pdf | HUMIRA® (adalimumab) Full Prescribing Information |
/htm/humira/humira_pi.html | HUMIRA® (adalimumab) Full Prescribing Information |
/pdf/humira_CHI.pdf | HUMIRA® (adalimumab) Full Prescribing Information - Chinese |
/pdf/humira_SPA.pdf | HUMIRA® (adalimumab) Full Prescribing Information - Spanish |
/pdf/humira_medguide.pdf | HUMIRA® (adalimumab) Medication Guide |
/pdf/ktab.pdf | K-TAB® (potassium chloride extended-release tablets, USP) |
/pdf/kaletracap_PI.pdf | KALETRA® (lopinavir/ritonavir) Capsules - Full Prescribing Information |
/pdf/kaletratabpi.pdf | KALETRA® (lopinavir/ritonavir) Tablets and KALETRA® (lopinavir/ritonavir) Oral Solution - Full Prescribing Information |
/pdf/kaletratab_medguide.pdf | KALETRA® (lopinavir/ritonavir) Tablets and KALETRA® (lopinavir/ritonavir) Oral Solution - Medication Guide |
/pdf/lupaneta_3_75_pi.pdf | LUPANETA PACK® (leuprolide acetate for depot suspension and norethindrone acetate tablets) 3.75 mg |
/pdf/lupaneta_11_25_pi.pdf | LUPANETA PACK® (leuprolide acetate for depot suspension and norethindrone acetate tablets) 11.25 mg |
/pdf/lupron3month11_25mg.pdf | LUPRON DEPOT® (leuprolide acetate for depot suspension) GYN 3 Month 11.25 mg |
/pdf/luprongyne_SPA.pdf | LUPRON DEPOT® (leuprolide acetate for depot suspension) GYN 3.75 mg and 3 Month 11.25 mg - Spanish |
/pdf/lupron3_75mg.pdf | LUPRON DEPOT® (leuprolide acetate for depot suspension) GYN 3.75 mg and 3 Month 11.25 mg |
/pdf/lupronuro_pi.pdf | LUPRON DEPOT® (leuprolide acetate for depot suspension) URO |
/pdf/lupronpediatric.pdf | LUPRON DEPOT-PED® (leuprolide acetate for depot suspension) |
/pdf/lupronpediatric_SPA.pdf | LUPRON DEPOT-PED® (leuprolide acetate for depot suspension) - Spanish |
/pdf/marinol_PI.pdf | MARINOL® (dronabinol) Capsules Full Prescribing Information |
/pdf/marinol_PIL.pdf | MARINOL® (dronabinol) Capsules Patient Information |
/pdf/mavyret_pi.pdf | MAVYRET™ (glecaprevir and pibrentasvir) tablets for oral use Full Prescribing Information |
/pdf/mavyret_SPA.pdf | MAVYRET™ (glecaprevir and pibrentasvir) tablets for oral use Full Prescribing Information - Spanish |
/pdf/mavyret_PIL.pdf | MAVYRET™ (glecaprevir and pibrentasvir) tablets for oral use Patient Information |
/pdf/mavyret_PIL_SPA.pdf | MAVYRET™ (glecaprevir and pibrentasvir) tablets for oral use Patient Information - Spanish |
/pdf/mivacron_PI.pdf | MIVACRON® Injection (mivacurium chloride) Full Prescribing Information |
/pdf/moderiba_PI.pdf | Moderiba™ (ribavirin, USP) Tablets |
/htm/moderiba/moderiba_pi.html | Moderiba™ (ribavirin, USP) Tablets |
/pdf/niaspan.pdf | NIASPAN® (niacin extended-release tablets) [film-coated] |
/pdf/Nimbex.pdf | NIMBEX® (cisatracurium besylate) |
/pdf/nimbex_novaplus_pi.pdf | NIMBEX® (cisatracurium besylate) Injection NOVAPLUS® Full Prescribing Information |
/pdf/nimbex_pi.pdf | NIMBEX® (cisatracurium besylate) Injection PremierProRx® Full Prescribing Information |
/pdf/norpi2a.pdf | NORVIR® Capsules (ritonavir capsules) |
/pdf/norvirtab_pi.pdf | NORVIR® (ritonavir tablets, oral solution, and oral powder) |
/pdf/orilissa_pi.pdf | ORILISSA® (elagolix) tablets, for oral use, 150 mg and 200 mg, Full Prescribing Information with Medication Guide |
/pdf/orilissa_pi_SPA.pdf | ORILISSA® (elagolix) tablets, for oral use, 150 mg and 200 mg, Full Prescribing Information with Medication Guide - Spanish |
/pdf/orilissa_medguide.pdf | ORILISSA® (elagolix) tablets, for oral use, 150 mg and 200 mg, Medication Guide |
/pdf/rinvoq_pi.pdf | RINVOQ™ (upadacitinib) extended-release tablets, for oral use Full Prescribing Information |
/pdf/rinvoq_pi_SPA.pdf | RINVOQ™ (upadacitinib) extended-release tablets, for oral use Full Prescribing Information - Spanish |
/pdf/rinvoq_medguide.pdf | RINVOQ™ (upadacitinib) extended-release tablets, for oral use Medication Guide |
/pdf/skyrizi_pi.pdf | SKYRIZI™ (risankizumab-rzaa) Full Prescribing Information |
/pdf/skyrizi_pi_SPA.pdf | SKYRIZI™ (risankizumab-rzaa) Full Prescribing Information - Spanish |
/pdf/skyrizi_medguide.pdf | SKYRIZI™ (risankizumab-rzaa) Medication Guide |
/pdf/survanta_pi.pdf | SURVANTA® (beractant) intratracheal suspension Full Prescribing Information |
/pdf/synthroid.pdf | SYNTHROID® (levothyroxine sodium tablets, USP) |
/htm/synthroid/synthroid_pi.html | SYNTHROID® (levothyroxine sodium tablets, USP) |
/pdf/synthroid_SPA.pdf | SYNTHROID® (levothyroxine sodium tablets, USP) - Spanish |
/pdf/tarka.pdf | TARKA® (trandolapril/verapamil HCI ER) |
/pdf/technivie_pi.pdf | TECHNIVIE® (ombitasvir, paritaprevir, and ritonavir tablets), for oral use Full Prescribing Information and Medication Guide |
/htm/technivie/technivie_pi.html | TECHNIVIE® (ombitasvir, paritaprevir, and ritonavir tablets), for oral use Full Prescribing Information and Medication Guide |
/pdf/technivie_medguide.pdf | TECHNIVIE® (ombitasvir, paritaprevir, and ritonavir tablets), for oral use Medication Guide |
/pdf/tricorpi.pdf | TRICOR® (fenofibrate) tablets |
/pdf/tridione_pi.pdf | TRIDIONE® (trimethadione) Tablets |
/pdf/trilipix_pi.pdf | TRILIPIX® (fenofibric acid) delayed-release capsules - Full Prescribing Information |
/pdf/ultanepi.pdf | ULTANE® (sevoflurane) |
/pdf/ultanenovaplus_pi.pdf | ULTANE® (sevoflurane) - NOVAPLUS® |
/pdf/venclexta.pdf | VENCLEXTA® (venetoclax tablets) for oral use Full Prescribing Information |
/htm/venclexta/venclexta_pi.html | VENCLEXTA® (venetoclax tablets) for oral use Full Prescribing Information |
/pdf/venclexta_SPA.pdf | VENCLEXTA® (venetoclax tablets) for oral use Full Prescribing Information - Spanish |
/pdf/venclexta_medguide.pdf | VENCLEXTA® (venetoclax tablets) for oral use Medication Guide |
/pdf/vicodin_apap_300mg_hydrocodone_5mg-7_5mg-10mg_PI.pdf | VICODIN® (hydrocodone bitartrate and acetaminophen tablets, USP) 5 mg/300 mg; VICODIN ES® (hydrocodone bitartrate and acetaminop... |
/pdf/viekirapak_pi.pdf | VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), co-packaged for oral use Full Prescribing Inf... |
/viekirapak/viekirapak_pi.html | VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), co-packaged for oral use Full Prescribing Inf... |
/pdf/viekirapak_medguide.pdf | VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets), co-packaged for oral use Medication Guide |
/pdf/viekiraxr_medguide.pdf | VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets, for oral use Medication Guide |
/pdf/viekiraxr_pi.pdf | VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets, for oral use Full Prescribing Informa... |
/htm/viekiraxr/viekiraxr_pi.html | VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets, for oral use Full Prescribing Informa... |
/pdf/Zemplarcappi.pdf | ZEMPLAR® (paricalcitol) Capsules |
/pdf/zemplarivpi.pdf | ZEMPLAR® (paricalcitol) Injection |
/htm/zemplariv/zemplariv_pi.html | ZEMPLAR® (paricalcitol) Injection |
User-agent: *
Disallow:
США - Даллас - 74.86.199.120
rackAID LLC
SoftLayer Technologies
HTTP/1.1 200 OK
Date: Sat, 21 Dec 2019 19:11:11 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 35198
Connection: close
Set-Cookie: AWSALB=bKiYLPOSSSITHIcF2BakwMkRXh6zckZ6ZvARpN5yH+1RBbV95X3VB1WA814K4MZ/tCvwcmHaz64aMoym1s6xbTFgUFCII5LxBBFmDLyj8HkusKVNopNdh7YnYI35; Expires=Sat, 28 Dec 2019 19:11:11 GMT; Path=/
Server: Apache
Age: 61318
Last-Modified: Sat, 21 Dec 2019 02:09:13 GMT
ETag: "897e-59a2d47d7e0ad"
Accept-Ranges: bytes
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"